Braskem SA Stock Forecast
NYSE: BAKIndustrialsMajor ChemicalsUSD
Market open · Delayed 15 min · as of Oct 8, 12:33 PM ET
BAK analyst consensus
Consensus (6 analysts)
underperform
Avg. price target
$1.90+1.33%
- Strong buy 0
- Buy 0
- Hold 3
- Sell 2
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 6 Wall Street analysts covering Braskem SA (2026-10-08), 0 rate the stock a buy or strong buy, 3 rate it a hold and 3 rate it a sell or strong sell, for a consensus rating of "underperform". The average 12-month price target is $1.90, with a high estimate of $3.20 and a low estimate of $1.50. The average target implies upside of 1.3% from the current price of $1.88.
The spread between the highest and lowest targets is 113.3%, a wide range that reflects significant disagreement among analysts. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for BAK.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 0 | 0% |
| Hold | 3 | 50% |
| Sell | 2 | 33% |
| Strong sell | 1 | 17% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $1.50 | -20.00% |
| Average target | $1.90 | +1.33% |
| High target | $3.20 | +70.67% |